Quest Diagnostics Incorporated DGX
236.32
(0.27)
(0.11%)
as of 25 Sep
- Market cap
- $26.2B
- P/E
- 24.8×
Follow DGX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Quest Diagnostics Incorporated (DGX) Gross margin
Quest Diagnostics Incorporated's gross margin over the twelve months to 30 June 2026 was 33.1%, down 0.1 percentage points from fiscal 2025 (33.2%). Over the past ten years it has ranged from 32.9% (fiscal 2024) to 39.0% (fiscal 2021); the current reading is higher than 27% of that period. That is below the Diagnostics & Research industry median of 50.9% and below the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 33.2% | 0.35 |
| FY2024 | 32.9% | (0.14) |
| FY2023 | 33.0% | (1.74) |
| FY2022 | 34.7% | (4.28) |
| FY2021 | 39.0% | 0.52 |
| FY2020 | 38.5% | 3.70 |
| FY2019 | 34.8% | 0.21 |
| FY2018 | 34.6% | (1.66) |
| FY2017 | 36.3% | 0.24 |
| FY2016 | 36.0% | (1.84) |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 33.8% | 1.21 |
| Mar 2026 | 32.5% | 0.11 |
| Dec 2025 | 32.4% | (1.27) |
| Sep 2025 | 33.7% | (0.45) |
| 42 more quarters | Free account |
Against its own ten years
Low 32.9%
High 39.0%
Ten-year median
34.8%
Current reading's percentile
27
Gross margin against peers
| Company | Gross margin |
|---|---|
| MEDP Medpace Holdings, Inc. compare | 72.4% |
| ILMN Illumina, Inc. compare | 66.4% |
| GH Guardant Health, Inc. compare | 65.0% |
| IDXX IDEXX Laboratories, Inc. compare | 62.5% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| RVTY Revvity Inc. compare | 55.0% |
| WAT Waters Corporation compare | 50.9% |
| DGX Quest Diagnostics Incorporated | 33.1% |
| LH Labcorp Holdings Inc. compare | 28.9% |
| Diagnostics & Research industry median | 50.9% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on DGX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement